← Open Payments lookup

MATT FRANCOM: Open Payments

NPI 1598910101 · WEST POINT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$300 in 18 payments from 12 companies in 2025. Trend: 2023 $195 · 2024 $349 · 2025 $300

Food & beverage: $300
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation2$39
Lilly USA, LLC2$39
Corcept Therapeutics2$39
Otsuka America Pharmaceutical, Inc.2$35
Almirall LLC1$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Organon LLC3$22
E.R. Squibb & Sons, L.L.C.1$20
ABBVIE INC.1$17
GlaxoSmithKline, LLC.1$14

Products named: COSENTYX, Korlym, REXULTI, Seysara, CAPLYTA, TALTZ, Sotyktu, VTAMA.

Industry payments across UT — which companies pay providers there.